Adam S Grossman is President and CEO of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 1.99 Million shares of ADMA, which is worth approximately $35.2 Million. The most recent transaction as insider was on Nov 22, 2024, when has been sold 48,967 shares (Common Stock) at a price of $21.1 per share, resulting in proceeds of $1,033,203. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.99M
3.43% 3M change
11.77% 12M change
Total Value Held $35.2 Million

Adam S Grossman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2024
SELL
Open market or private sale
$1,033,203 $21.1 p/Share
48,967 Reduced 2.4%
1,989,007 Common Stock
Sep 30 2024
SELL
Payment of exercise price or tax liability
$434,822 $19.99 p/Share
21,752 Reduced 1.06%
2,037,974 Common Stock
Aug 27 2024
SELL
Open market or private sale
$6,731,965 $17.29 p/Share
389,356 Reduced 15.9%
2,059,726 Common Stock
Aug 27 2024
BUY
Exercise of conversion of derivative security
$1,222,577 $3.14 p/Share
389,356 Added 13.72%
2,449,082 Common Stock
Aug 26 2024
SELL
Open market or private sale
$4,190,566 $17.69 p/Share
236,889 Reduced 10.31%
2,059,726 Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$1,634,534 $6.9 p/Share
236,889 Added 9.35%
2,296,615 Common Stock
Jun 30 2024
SELL
Payment of exercise price or tax liability
$243,187 $11.18 p/Share
21,752 Reduced 1.05%
2,059,726 Common Stock
Jun 14 2024
SELL
Open market or private sale
$1,072,000 $10.72 p/Share
100,000 Reduced 4.58%
2,081,475 Common Stock
Jun 14 2024
SELL
Bona fide gift
-
10,000 Reduced 0.46%
2,181,475 Common Stock
Jun 14 2024
SELL
Other acquisition or disposition
$1,476,600 $3.21 p/Share
460,000 Reduced 17.35%
2,191,475 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$143,563 $6.6 p/Share
21,752 Reduced 0.81%
2,651,475 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$177,180 $6.16 p/Share
28,763 Reduced 1.06%
2,673,227 Common Stock
Mar 06 2024
SELL
Payment of exercise price or tax liability
$336,618 $6.12 p/Share
55,003 Reduced 2.0%
2,701,990 Common Stock
Feb 29 2024
SELL
Payment of exercise price or tax liability
$51,391 $5.36 p/Share
9,588 Reduced 0.35%
2,756,993 Common Stock
Feb 26 2024
BUY
Grant, award, or other acquisition
-
557,728 Added 16.78%
2,766,581 Common Stock
Feb 25 2024
SELL
Payment of exercise price or tax liability
$118,123 $5.26 p/Share
22,457 Reduced 1.01%
2,208,853 Common Stock
Dec 31 2023
SELL
Payment of exercise price or tax liability
$104,217 $4.52 p/Share
23,057 Reduced 1.02%
2,231,310 Common Stock
Sep 30 2023
SELL
Payment of exercise price or tax liability
$67,010 $3.58 p/Share
18,718 Reduced 0.82%
2,254,367 Common Stock
Aug 18 2023
SELL
Open market or private sale
$1,037,500 $4.15 p/Share
250,000 Reduced 9.91%
2,273,085 Common Stock
Aug 16 2023
SELL
Open market or private sale
$13 $4.38 p/Share
3 Reduced 0.0%
2,523,085 Common Stock
Aug 15 2023
SELL
Open market or private sale
$2,317,529 $4.54 p/Share
510,469 Reduced 11.04%
4,113,075 Common Stock
Aug 15 2023
SELL
Payment of exercise price or tax liability
$7,329,840 $4.61 p/Share
1,589,987 Reduced 38.66%
2,523,088 Common Stock
Aug 15 2023
BUY
Exercise of conversion of derivative security
$6,133,340 $2.92 p/Share
2,100,459 Added 31.24%
4,623,544 Common Stock
Jun 30 2023
SELL
Payment of exercise price or tax liability
$73,988 $3.69 p/Share
20,051 Reduced 0.79%
2,523,085 Common Stock
Mar 31 2023
SELL
Payment of exercise price or tax liability
$59,093 $3.31 p/Share
17,853 Reduced 0.7%
2,543,139 Common Stock
ASG

Adam S Grossman

President and CEO
Ramsey, NJ

Track Institutional and Insider Activities on ADMA

Follow ADMA BIOLOGICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA